Our Team – FSD Pharma

Our Team

Dr Raza Bokhari

Executive Co-Chairman & Interim CEO

Dr Raza Bokhari Executive Co-Chairman & Interim CEO Recipient of Philadelphia Business Journal’s “40 under 40” award, physician turned entrepreneur, Dr. Raza Bokhari has over the past several years developed outstanding expertise in aggregating and accelerating life sciences and healthcare services companies. He has a vast knowledge base of developing creative concepts, implementing programs and […]

View Profile

Anthony Durkacz

Executive Co-Chairman of the Board and Founder

Anthony Durkacz is currently a Director and Executive Vice President at First Republic Capital Corp. since January 2014. First Republic Capital Corp. has acted as the exclusive agent of the Company and has raised approximately $53,000,000.00of equity capital to date. Previously he was President of Capital Ideas Investor Relations from January to December 2013. Before that he was a Director and CFO of Snipp Interactive Inc. (TSXV: SPN) from January 2011 to January 2013. He was instrumental in the financing and public listing of the mobile marketing company with operations in Canada, the USA, Mexico and India. Mr. Durkacz is also the owner and President of Fortius Research & Trading Corp., which provides financial and investor relations consulting services to micro and small cap companies in various sectors, and develops investment strategies for high net worth individuals. From 2006 to 2009, he served as COO and CFO of MKU Canada Inc. engaging in mergers and acquisitions globally, and from 2002 to 2006 he served as the CFO of Astris Energi Inc., a dually listed public company in the USA and Canada which was acquired by an international conglomerate. He began his career at TD Securities on the capital markets trading floor. Mr. Durkacz holds an Honours Bachelor of Business Administration from Brock University with a major in both Accounting and Finance.

View Profile

Zeeshan Saeed

President, Founder and Director

Mr. Saeed is an entrepreneur and is one of the founding members of FV Pharma inc which is now wholly owned by FSD Pharma Inc. He has been involved with the company from the beginning since July of 2013. Mr. Saeed provided consulting advice to FV Pharma and was instrumental for raising the initial seed capital. He played a key role in bringing together a team of professionals in the development of the Corporation business plan as well as bringing key relationships to the company. He has experience in international capital markets and has helped various startups with the process of raising initial funding and getting listed on various stock exchanges. Mr. Saeed is an Engineer by qualification and is currently the President and Director of FSD Pharma inc. Before entering capital markets Mr. Saeed was the founder and CEO of Platinum telecommunications inc. Mr. Saeed grew the company to a stage at which it was taken over by a public company.

View Profile

David Urban

Director

Director Driven leader and board member with comprehensive accomplishments leading corporate development, government affairs, coalitions, legislative influence, political campaigns and cross-functional teams to achieve goals. Known as an innovative thinker with strong telecommunications, finance, health care, technology, defense, legal, trade and energy acumen. Demonstrated success advising leaders at the highest level of business and government […]

View Profile

Donal Carroll, CPA

Chief Financial Officer

Donal Carroll has been Chief Financial Officer of Newgioco Group, Inc. since June 06, 2017. Mr. Carroll is a Business Executive who is currently Chief Financial Officer of World Class Extractions Inc. He has 20 years of corporate finance leadership and public company experience, as well as deep expertise in syndicate investing both in equity and debt securities. With a balance of prudent financing practices and unique insights, Mr. Carroll has successfully guided companies for expansion and growth. Throughout his tenure with Danaher, Alberto Culver – now Unilever (NYSE:UL) and Cardinal Meats, He was instrumental in major restructuring activities, mergers and acquisitions and the implementations of new internal controls and ERP systems resulting in significant efficiencies through periods of substantial change and strong company growth. Mr. Carroll has been Independent Director of Bird River Resources Inc., since September 15, 2017. He serves as Member of the Board of Directors at FSD Pharma Inc. Mr. Carroll holds a CPA-CMA designation as well as a Bachelor of Commerce degree from University College Dublin (UCD).

View Profile

Gerald Goldberg, CPA, CA

Director

Mr. Goldberg is a Chartered Professional Accountant and a former senior partner at two major accounting firms. Mr. Goldberg has over 30 years' of audit experience and was the head of the public company audit division of a major firm. He has industry expertise in cannabis cultivation and aggregation, distribution, retail, mining natural resource and oil & gas, real estate, "not-for-profit" entities and manufacturing industries, with a strong emphasis on taxation and business advisory services. He was active in corporate finance and development and was involved in the structure and design of numerous innovative financing instruments, tax shelters and syndications, both in Canada and the US. He was actively involved with the audit of various public Canadian, US, Chinese and other foreign companies listed in the US and Canada. Mr. Goldberg holds the designation of C.T.A. from the University of South Africa and is a member of the Institute of Chartered Professional Accountants of Ontario and the Public Accountants Council of Ontario. Mr. Goldberg was also active in the Medical Cannabis Industry and until recently was Interim CEO of an integrated licensed producer and patient aggregator. Mr. Goldberg is presently the CEO and Executive Chairman of a late-stage applicant for a Cannabis Act standard processor license.

View Profile

Dr Zohar Koren

Head of Scientific Advisory Board

Dr. Koren is co-founder and CEO of SciCann Therapeutics Inc., a Canadian-Israeli speciality pharmaceutical firm dedicated to the development of cutting edge technologies in the pharmaceutical cannabinoid space. Prior to that, Dr. Koren served as VP BD of Mor Research Applications, the technology transfer office of Clalit Healthcare Services, Israel’s largest medical insurer and healthcare provider. He also served as VP BD of Talent Biotechs, a pharmaceutical company which developed CBD based therapies for GVHD (Graft Vs Host Disease), until its acquisition by Kalytera Inc. in 2017. Previously, Dr. Koren served as Co-founder, CEO and CFO of Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a developer of cannabis based therapies for oncology patients, and prior to that as Director of Business Development at Aposense Ltd (TASE:APOS), a developer of novel pharmaceutical products in the oncology, CNS and metabolic disease fields.

View Profile

Sandy Huard

Head of Investor Relations

Head of Investor Relations Sandy is a professional marketing and communications executive, senior strategist and consultant with over 21 years of marketing and sales experience leading national marketing teams, driving sales performance and launching national brands in the financial services industry. Throughout her career, Sandy has worked with banks, technology companies, wireless carriers, and agencies […]

View Profile